Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study
Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large
Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis
Perioperative characteristics of 121 radical prostatectomy patients... | Download Scientific Diagram
PD07-09 EFFECT OF ANASTROZOLE ON PROSTATE SPECIFIC ANTIGEN VALUES IN HYPOGONADAL, SUBFERTILE MEN | Journal of Urology
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
PSA Testing | ZERO Prostate Cancer
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting | PLOS ONE
Understanding PSA Levels & The PSA Test | HALO Precision Diagnostics
Cureus | Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints | Article
JCM | Free Full-Text | The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus
Table 5.2 from Prostate Specific Antigen (PSA) growth curves: A method to improve prostate cancer screening | Semantic Scholar
Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL - Ang - 2016 - BJU International - Wiley Online Library
Frontiers | Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer
